PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Phenotype | C0011570|depression |
| Sentences | 45 |
| PubMedID- 25535442 | The cdss was more specific and valid for the assessment of depression in patients with schizophrenia than other general scales measuring depression (hamilton rating scale for depression) or depression related sub-scores of general scales for schizophrenia (panss-d). |
| PubMedID- 22018413 | Our results also showed that better cognitive insight is related to worse depression in patients with schizophrenia spectrum disorders, but not in nonpsychiatric individuals. |
| PubMedID- 23355781 | First, the depression and psychotic symptoms of the patients with schizophrenia in this study were moderately low. |
| PubMedID- 23199176 | Treatment of depression in schizophrenia consists of a combination of pharmacologic and psychosocial approach. |
| PubMedID- 22796716 | Background: the aim of this study was to compare two measures of depression in patients with schizophrenia and schizophrenia spectrum disorder, including patients with delusional and schizoaffective disorder, to conclude implications for their application. |
| PubMedID- 21822190 | Results: the clinical depression seen in patients with schizophrenia differed significantly from that in patients with depressive disorder. |
| PubMedID- 24715953 | Impulsivity and motivational deficits are complex behavioral phenotypes implicated in a number of psychiatric disorders including attention deficit hyperactivity disorder (adhd), mania and depression associated with bipolar disorder, schizophrenia, pathological gambling, borderline personality disorder, and substance abuse3. |
| PubMedID- 26317435 | depression comorbid with schizophrenia) without concurrent physical long-term conditions. |
| PubMedID- 21451190 | Conclusion: the hungarian version of cdss can be used to assess depression in schizophrenia and we recommend the introduction of the scale into practice in hungary. |
| PubMedID- 25834445 | Treatments for depression in schizophrenia mainly focus on addressing the underlying factors of depressive symptoms, including medications and psychosocial treatments. |
| PubMedID- 21453977 | depression in schizophrenia has been recognized as one of the important factors influencing the quality of life (qol). |
| PubMedID- 20334680 | The cdss is primarily developed to assess depression in patients with schizophrenia, and may not be the optimal tool in assessing depressive features in other diagnostic categories. |
| PubMedID- 23401771 | schizophrenia patients with clinically significant depression at baseline also had a significant reduction in depressive symptoms, which is consistent with previous studies which have indicated that atypical antipsychotics may be effective in reducing depressive symptoms accompanying schizophrenia [40, 48, 69–71]. |
| PubMedID- 26297373 | Psychotic illness included schizophrenia, schizoaffective, bipolar with psychosis, depression with psychosis, delusional disorder, postanoxic or interferon-related psychosis, substance-induced psychosis and psychosis not otherwise specified. |
| PubMedID- 26384012 | Conclusion: results suggest that nos1ap variants are associated with various forms of depression in schizophrenia and are more prevalent in males. |
| PubMedID- 22456094 | Background: subsyndromal symptoms of depression (ssd) in patients with schizophrenia are common and clinically important. |
| PubMedID- 25705731 | They have not been shown to harm or to be beneficial in depression associated with schizophrenia, bipolar disorder or substance dependence. |
| PubMedID- 22214874 | depression in schizophrenia is defined in different ways, i.e. |
| PubMedID- 26508952 | Hence, diagnosis of comorbid depression in schizophrenia is challenging but worthy of clinical attention to evaluate the risk of rehospitalization. |
| PubMedID- 22021955 | [14] it has also been shown that the risk of suicide in schizophrenia is more associated with depression and specific affective symptoms (like agitation, a sense of worthlessness and hopelessness), rather than with the core symptoms of schizophrenia (like delusions and hallucinations). |
| PubMedID- 22281452 | There was a positive association between mortality and subclinical depression among individuals with schizophrenia (hr 1.5; 1.1-2.2; p=0.019) but a negative association with subclinical and more severe depression among those with schizoaffective disorder (hr 0.1; 0.02-0.4; p=0.001 and 0.3; 0.1-0.8; p=0.021, respectively). |
| PubMedID- 23623454 | Results showed that, after controlling for depression, patients with schizophrenia achieved higher scores than control subjects on six emss. |
| PubMedID- 19711335 | Background: subsyndromal symptoms of depression (ssd) in patients with schizophrenia are common and clinically important. |
| PubMedID- 22260713 | Criteria for exclusion are: a depression as part of a psychotic disorder, schizophrenia, schizoaffective disorder or obsessive compulsive disorder, anxiety disorder as primary diagnosis, patients in long stay facilities (including day-care) or with complex pathology and treatment resistant depression (inpatients, treated by protocol more than 6 months with no remission); patients with significant cardiovascular disease or other medical conditions as contra-indication for exercise therapy, walking and/or running such as joint and hip pathology; alcohol/drugs dependence as a primary diagnosis, pregnancy, high suicide risk with treatment on a closed ward, or already being physically active on a regular basis (2-3 times a week on a high-intensity). |
| PubMedID- 23825848 | [1] anti-depressants are prescribed for treatment of comorbid depression in schizophrenia as well as mood symptoms that may be part of the core illness. |
| PubMedID- 22928716 | A smaller number of studies compare public knowledge, attitudes and/or reactions toward two disorders (usually depression with schizophrenia), and still fewer contrast depression and schizophrenia with other diagnostic groups such as substance misuse disorders or physical disabilities [10]. |
| PubMedID- 24586189 | Among the most pronounced candidates in our list are neuronal genes tmem132d (pihs = 0.00087, pclr = 0.00021), cacna1c (pihs = 0.48366, pclr = 0.00013), nrxn1 (pihs = 0.00396, pclr = 0.00018) and npas3 (pihs = 0.34897, pclr = 0.00137) reported as candidate qtls for anxiety-related behavior, major depression and high risk of developing schizophrenia [41], [42], [43], [44]. |
| PubMedID- 22661807 | In addition, higher levels of insight in schizophrenia have been associated with depression and hopelessness, but the causal direction of the relationship is unclear and the data are inconclusive. |
| PubMedID- 24891716 | [6] in conclusion, our reports suggest rimonabant can result in new onset depression in patients with schizophrenia and one has to be cautious in initiating rimonabant though there are studies that suggest the contrary. |
| PubMedID- 21836676 | However, dopamine-β-hydroxylase activity did not differ between healthy controls, acute schizophrenia patients, subjects with non-psychotic depression and mania. |
| PubMedID- 20513687 | Common diagnoses reported were depression (74% of units), schizophrenia or other psychoses (42% of units), and dementia or alzheimer's disease (57% of units). |
| PubMedID- 23944118 | Eight of the 10 had previously been examined in psychiatric clinics, which identified two as having depression, two with schizophrenia, one with obsessive-compulsive disorder, and one with autism/asperger syndrome, and there was no diagnosis for the other two. |
| PubMedID- 24640550 | [persistent depression with minute schizophrenia-like symptoms--from the viewpoint of "pluridimensional psychiatry"]. |
| PubMedID- 26419356 | Since it is estimated that comorbid depression occurs in 50 % of patients with schizophrenia [50], this distinction is more conjectural than realistic. |
| PubMedID- 21983496 | Randomized, controlled clinical trials examining adjunctive use of antidepressants, anxiolytics and sedative/hypnotics to target symptoms of anxiety, depression, and insomnia in patients with schizophrenia are needed to adequately address the efficacy of these interventions. |
| PubMedID- 22112362 | depression in schizophrenia was associated with worse than that in the other conditions life adjustment after discharge, such as unemployment, low activity, general lack of satisfaction, suicidal tendencies, and a large number of subsequent re-hospitalizations. |
| PubMedID- 21070104 | The majority of pharmacists correctly identified depression (92%) with fewer recognizing schizophrenia (79%). |
| PubMedID- 23537843 | Psychological models of depression in schizophrenia have proposed that cognitive structures (e.g., self-esteem, dysfunctional beliefs) may have a role in the development and maintenance of depression. |
| PubMedID- 24429962 | A cohort study of depression in schizophrenia and schizophrenia spectrum disorders was conducted in four russian regional mental health services with the use of simultaneous one-day census on october 20, 2011. |
| PubMedID- 23661632 | The overall concordance between 4 categorical diagnostic groups (schizophrenia, mania with psychosis, psychotic depression and schizoaffective disorder) and dimensional symptom ranged from 62.2% to 73.1% (when the schizoaffective group was excluded). |
| PubMedID- 21485748 | Exclusion criteria were: depression with suicidal risk, schizophrenia, schizoaffective disorders, eating disorders, bipolar illness, hyperthyroidism, vitamin d deficiency, or other conditions or treatments that might affect bone turnover, and menopause, defined as the absence of spontaneous menses during the preceding 6 months. |
| PubMedID- 23840971 | Moreover, compared to both control subjects and patients having major depression, patients with schizophrenia and those with bipolar disorder have significantly elevated ratio of calretinin to calbindin [7]. |
| PubMedID- 24955752 | depression is common in patients with schizophrenia and can have considerable debilitating effects. |
| PubMedID- 24280478 | Objectives: to examine the effects of a group music therapy on psychiatric symptoms and depression for patient with schizophrenia in a psychiatric nursing home. |
| PubMedID- 21489416 | A better understanding of the cognitive component of insight in schizophrenia with comorbid depression may contribute to develop more efficient cognitive strategies, thus improving patient outcome. |
Page: 1